Understanding pharmacology in nursing practice / (Record no. 673923)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06310nam a2200637Ii 4500 |
| 001 - CONTROL NUMBER | |
| control field | on1141858470 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250919151303.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200226s2020 sz a ob 000 0 eng d |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER | |
| National bibliography number | GBC038342 |
| Source | bnb |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
| Record control number | 019715477 |
| Source | Uk |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783030320041 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3030320049 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9783030320034 |
| Qualifying information | (print) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 3030320030 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-3-030-32004-1 |
| Source of number or code | doi |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | com.springer.onix.9783030320041 |
| Source of stock number/acquisition | Springer Nature |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EBZ |
| Language of cataloging | eng |
| Transcribing agency | EBZ |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM300 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MQC |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED058000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MQC |
| Source | thema |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1 |
| Edition information | 23 |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) | |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) | eBook PPUKM |
| 245 00 - TITLE STATEMENT | |
| Title | Understanding pharmacology in nursing practice / |
| Statement of responsibility, etc. | Pauline Hood, Ehsan Khan, editors. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2020. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (viii, 411 pages) : |
| Other physical details | color illustrations |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 341 0# - ACCESSIBILITY CONTENT | |
| Content access mode | textual |
| Source | sapdv |
| Materials specified | EBSCOhost |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes bibliographical references. |
| 532 #0 - ACCESSIBILITY NOTE | |
| 3 | EBSCOhost |
| Summary of accessibility | 'EBSCO evaluates our products based on the Web Content Accessibility Guidelines (WCAG) and the related Section 508 and EN 301 549 regulations in the US and EU. Most EBSCO products are substantially conformant with WCAG 2.2 level AA.' Source: https://connect.ebsco.com/s/article/EBSCO-VPATs?language=en_US. Last accessed April 22, 2025. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Online resource; title from PDF title page (SpringerLink, viewed February 26, 2020). |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- Preface -- Contents -- Part I: Legal and Ethical Issues -- 1: Legal and Ethical Issues Associated with Medication -- 1.1 Introduction -- 1.2 Professionalism and Accountability -- 1.3 Accountability -- 1.4 Legal Component of Accountability -- 1.5 Duty of Care -- 1.6 Safeguards in Practice -- 1.7 Consent -- 1.8 Ethical Principles -- 1.9 Summary -- 1.10 Useful Websites [Accessed 12 March 2019] -- Multiple Choice Questions -- Answers -- References -- Further Reading -- Part II: Principles of Pharmacology -- 2: Pharmacokinetics and Pharmacodynamics -- 2.1 Introduction |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.2 Pharmacokinetics -- 2.2.1 Absorption -- 2.2.1.1 Oesophageal Transit -- 2.2.1.2 Food -- 2.2.1.3 Gastrointestinal Motility -- 2.2.1.4 Drug Efflux Proteins -- 2.2.1.5 First-Pass Effect -- 2.2.1.6 Absorption Via Other Routes -- 2.2.2 Distribution -- 2.2.2.1 Fluid Compartments -- 2.2.2.2 Volume of Distribution -- 2.3 Drug Metabolism -- 2.3.1 Enzymatic Defence -- 2.3.2 Forms of Drug Metabolism -- 2.3.3 Phase I Metabolism -- 2.3.4 Phase II Metabolism -- 2.3.5 Phase III Metabolism -- 2.3.6 Enzyme Substrates -- 2.3.6.1 Clinical Importance of Substrate Interactions |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.3.7 Enzyme Inhibitors -- 2.3.8 Enzyme Inducers -- 2.4 Clearance -- 2.4.1 Renal Clearance -- 2.4.1.1 Formation of the Concentration Gradient -- 2.4.2 Liver Clearance -- 2.5 Drug Half-Life -- 2.6 Therapeutic Index -- 2.7 Pharmacokinetics: Summary -- 2.8 Pharmacodynamics -- 2.9 Ion Channels -- 2.10 Ligands -- 2.11 Ion Pumps -- 2.12 Receptor -- 2.13 Enzymes -- 2.14 Cell Membranes -- 2.15 Receptor Theory -- 2.15.1 Affinity -- 2.16 Drug Interactions with Their Target -- 2.16.1 Agonist -- 2.16.2 Antagonists -- 2.17 Categories -- 2.18 Competitive Antagonism |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.18.1 Non-competitive Antagonist -- 2.18.2 Partial Agonists -- 2.19 Receptor Classification -- 2.20 Summary -- Multiple Choice Questions -- Answers -- References -- 3: Drug Formulations -- 3.1 Introduction -- 3.2 Necessity for Different Dosage Forms -- 3.3 General Considerations in the Design of Dosage Forms -- 3.4 Drug Stability -- 3.5 Product Shelf Life -- 3.6 Pharmaceutical Excipients -- 3.7 Identifying Patient Reactions to Excipients in Practice -- 3.8 Summary -- 3.9 Pharmaceutical Dosage Forms -- 3.9.1 Introduction -- 3.9.2 Solid Dosage Forms -- 3.9.3 Capsules |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3.9.4 Tablets -- 3.9.5 Compressed Tablets -- 3.9.6 Buccal or Sublingual Tablets -- 3.9.7 Extended-Release Dosage Forms -- 3.9.8 Guidance on Dosage Forms That Cannot Be Altered -- 3.9.9 Semi-solid Dosage Forms -- 3.9.9.1 Creams -- 3.9.9.2 Hydrophobic Creams (w/o) -- 3.9.9.3 Hydrophilic Creams (o/w) -- 3.9.9.4 Gels -- 3.9.9.5 Hydrophobic Gels -- 3.9.9.6 Hydrophilic Gels -- 3.9.9.7 Ointments -- 3.9.9.8 Hydrophobic Ointments -- 3.9.9.9 Water-Emulsifying Ointments -- 3.9.9.10 Hydrophilic Ointments -- 3.9.9.11 Pastes -- 3.9.10 Guidance for the Use of Semi-solid Forms |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This textbook provides a structured, informed approach to the understanding and appreciation of drug action and effect providing a detailed description and discussion of pharmacokinetics and pharmacodynamics for nurses. The text focuses and emphasizes safe prescribing and administration of medication highlighting the possible harm to patient in terms of adverse reactions. This book also includes the seldom addressed facet of pharmacotherapeutics; drug formulation as applied to practice, and adverse reactions. It informs on the medication used to manage diabetes mellitus, respiratory disease, gastrointestinal tract, the central nervous system and many other affections. Uniting these essential pharmacological processes and applying them to physiological system based medications, this work highlights issues relevant to drug interaction and important nursing responsibilities associated with administration/prescribing. The overall aim of the text is to equip the nurse with an understanding of issues related to pharmacotherapeutics that is aligned to current nursing roles and statutory requirements. . |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Added to collection customer.56279.3 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nursing. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hood, Pauline, |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Khan, Ehsan, |
| Relator term | editor. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| International Standard Book Number | 3030320030 |
| -- | 9783030320034 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | EBSCOhost |
| Uniform Resource Identifier | <a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2540682">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2540682</a> |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
| a | .b17073303 |
| b | 2025-07-28 |
| c | 2025-07-21 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Suppress in OPAC | No |
| Call number prefix | eBook PPUKM |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) | |
| Library | |
| Operator's initials, OID (RLIN) | 2025-07-21 |
| Cataloger's initials, CIN (RLIN) | m |
| Material Type (Sierra) | E-Book |
| Language | English |
| Country | |
| -- | 0 |
| -- | .b17073303 |
No items available.